Hows and Whys of Skin Biopsy Test For Parkinson's Disease

A commercially available skin test to aid Parkinson's disease diagnosis is available in most states. How do clinicians use it? Could it help in the development of alpha-synuclein-targeted therapies?

Related Keywords

Boca Raton ,Florida ,United States ,Arizona ,Germany ,New York ,American ,German ,Todd Levine ,Mark Frasier ,Stuart Isaacson ,Fritz Heinrich Lewy ,American Academy Of Neurology ,National Institutes Of Health ,Movement Disorders Center ,Life Sciences ,Michaelj Fox Foundation ,Syn One Test ,National Institutes ,American Academy ,Parkinsons Disease ,Biopsy ,Nerves ,Insurance ,Neurotransmitter ,Biologic Therapy ,Hiv Infection ,Shiv ,Biomarker ,Iological Marker ,Disease Modifying Therapy ,Mt ,Movement Disorder ,Multiple Systems Atrophy ,Sa Multiple Systems Atrophy ,Neurodegenerative Disease ,